Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,664 | 4,756 | 2,187 | N/A | N/A |
| Depreciation Amortization | 678 | 394 | 197 | N/A | N/A |
| Accounts receivable | -2,725 | -3,014 | -1,492 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,887 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,731 | -1,365 | -694 | N/A | N/A |
| Other Operating Activity | 1,249 | 4,108 | 2,044 | 0 | 0 |
| Operating Cash Flow | $11,485 | $4,879 | $2,242 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,339 | -1,288 | -526 | N/A | N/A |
| Purchase Sale Intangibles | -2,742 | -2,742 | -1,891 | N/A | N/A |
| Other Investing Activity | -3,036 | -3,036 | -2,185 | 0 | 0 |
| Investing Cash Flow | $-8,374 | $-4,324 | $-2,711 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 66 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 8,865 | 7,591 | 2,535 | N/A | N/A |
| Dividend Paid | -1,577 | -1,077 | -499 | N/A | N/A |
| Other Financing Activity | 440 | 440 | 440 | 0 | 0 |
| Financing Cash Flow | $7,794 | $6,954 | $2,475 | $N/A | $N/A |
| Exchange Rate Effect | 3 | 5 | -5 | N/A | N/A |
| Beginning Cash Position | 12,352 | 12,352 | 12,352 | N/A | N/A |
| End Cash Position | 23,259 | 19,867 | 14,353 | N/A | N/A |
| Net Cash Flow | $10,907 | $7,514 | $2,001 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,485 | 4,879 | 2,242 | N/A | N/A |
| Capital Expenditure | -5,339 | -1,288 | -526 | N/A | N/A |
| Free Cash Flow | 6,146 | 3,591 | 1,716 | 0 | 0 |